Opus Genetics, Inc. (IRD) vs Orchestra BioMed Holdings, Inc. (OBIO)
- Opus Genetics, Inc. IRD 3.81 −5.93%
- Orchestra BioMed Holdings, Inc. OBIO 5.45 −5.05%
Opus Genetics, Inc. and Orchestra BioMed Holdings, Inc. are both Biotechnology companies. Opus Genetics, Inc. and Orchestra BioMed Holdings, Inc. are of similar size ($345.0M and $336.9M). Orchestra BioMed Holdings, Inc. grew revenue faster over the last twelve months: 986.1% against −36.1%. Orchestra BioMed Holdings, Inc. has the higher net margin (−186.3% vs −1,091.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Orchestra BioMed Holdings, Inc. leads on 9 and Opus Genetics, Inc. on 6.
Valuation
Profitability
| Metric | IRD | OBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 99.51% | 65.16% |
| Operating margin | (513.47%) | (181.36%) | 0.00% |
| Net margin | (1,091.82%) | (186.30%) | 0.00% |
| Free cash flow margin | (412.61%) | (184.83%) | 0.00% |
| Return on equity | (4,796.52%) | (607.32%) | (56.36%) |
| Return on assets | (163.50%) | (75.16%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack